Status:
COMPLETED
Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis
Lead Sponsor:
MaineHealth
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
6-11 years
Phase:
NA
Brief Summary
There are few studies evaluating best bathing practices in the management of pediatric atopic dermatitis (AD). Trans-epidermal water loss plays a key role in the pathophysiology of AD. In concert with...
Detailed Description
To evaluate the effectiveness of twice daily soak-and-seal baths for improving severity of disease in children with AD, we implemented a randomized clinical trial using a single-blind, crossover-contr...
Eligibility Criteria
Inclusion
- Infants and children ages 6 months to 11 years of age with moderate to severe atopic dermatitis according to the criteria of Hanifin and Rajka.
Exclusion
- Patients with suspected or established primary immune deficiency, patients receiving systemic corticosteroids, ultraviolet light therapy, immuno-therapeutic agents, and/or anti-infective drugs less than 1 month from the onset of the study.
Key Trial Info
Start Date :
November 14 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 21 2017
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT03397979
Start Date
November 14 2011
End Date
March 21 2017
Last Update
January 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allergy and Asthma Associates of Maine
Portland, Maine, United States, 04102